Cargando…

Herpes zoster and long-term vascular risk: a retrospective cohort study

Herpes zoster (HZ) represents a serious health problem in the general population due to its abundance and complications. Stroke and acute myocardial infarction are well-documented short-term complications of HZ, primarily due to vasculopathy in the cerebral and coronary arteries. However, no major s...

Descripción completa

Detalles Bibliográficos
Autores principales: Horev, Amir, Horev, Anat, Gordon-Irshai, Adi, Gordon, Michal, Andre, Nicolas, Ifergane, Gal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911591/
https://www.ncbi.nlm.nih.gov/pubmed/36759695
http://dx.doi.org/10.1038/s41598-023-29667-w
_version_ 1784885019516338176
author Horev, Amir
Horev, Anat
Gordon-Irshai, Adi
Gordon, Michal
Andre, Nicolas
Ifergane, Gal
author_facet Horev, Amir
Horev, Anat
Gordon-Irshai, Adi
Gordon, Michal
Andre, Nicolas
Ifergane, Gal
author_sort Horev, Amir
collection PubMed
description Herpes zoster (HZ) represents a serious health problem in the general population due to its abundance and complications. Stroke and acute myocardial infarction are well-documented short-term complications of HZ, primarily due to vasculopathy in the cerebral and coronary arteries. However, no major study to date has specifically demonstrated that HZ is a long-term risk factor for all Major Adverse Cardiac and Cerebrovascular Events (MACCE). A retrospective cohort study was conducted analyzing the association between HZ and MACCE. We compared HZ patients diagnosed between 2001 and 2018 and a matched control group. The model was stratified according to matched pairs and adjusted for age, socioeconomic status, history of dyslipidemia, and prior myocardial infarction (MI). Association between HZ exposure and stroke was assessed through a multivariable Cox regression analysis. The study included 41,930 patients, with 20,965 patients in each group. The risk of MACCE was 19% higher among HZ patients in the first year of follow up (P < 0.001). Antiviral treatment did not positively affect long-term survival among HZ patients (P < 0.001). These results suggest that HZ is a marker of long-term vascular risk. Additional studies will be needed to further evaluate this risk, the impact of HZ vaccination on such risk, and potential mitigation strategies.
format Online
Article
Text
id pubmed-9911591
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99115912023-02-11 Herpes zoster and long-term vascular risk: a retrospective cohort study Horev, Amir Horev, Anat Gordon-Irshai, Adi Gordon, Michal Andre, Nicolas Ifergane, Gal Sci Rep Article Herpes zoster (HZ) represents a serious health problem in the general population due to its abundance and complications. Stroke and acute myocardial infarction are well-documented short-term complications of HZ, primarily due to vasculopathy in the cerebral and coronary arteries. However, no major study to date has specifically demonstrated that HZ is a long-term risk factor for all Major Adverse Cardiac and Cerebrovascular Events (MACCE). A retrospective cohort study was conducted analyzing the association between HZ and MACCE. We compared HZ patients diagnosed between 2001 and 2018 and a matched control group. The model was stratified according to matched pairs and adjusted for age, socioeconomic status, history of dyslipidemia, and prior myocardial infarction (MI). Association between HZ exposure and stroke was assessed through a multivariable Cox regression analysis. The study included 41,930 patients, with 20,965 patients in each group. The risk of MACCE was 19% higher among HZ patients in the first year of follow up (P < 0.001). Antiviral treatment did not positively affect long-term survival among HZ patients (P < 0.001). These results suggest that HZ is a marker of long-term vascular risk. Additional studies will be needed to further evaluate this risk, the impact of HZ vaccination on such risk, and potential mitigation strategies. Nature Publishing Group UK 2023-02-09 /pmc/articles/PMC9911591/ /pubmed/36759695 http://dx.doi.org/10.1038/s41598-023-29667-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Horev, Amir
Horev, Anat
Gordon-Irshai, Adi
Gordon, Michal
Andre, Nicolas
Ifergane, Gal
Herpes zoster and long-term vascular risk: a retrospective cohort study
title Herpes zoster and long-term vascular risk: a retrospective cohort study
title_full Herpes zoster and long-term vascular risk: a retrospective cohort study
title_fullStr Herpes zoster and long-term vascular risk: a retrospective cohort study
title_full_unstemmed Herpes zoster and long-term vascular risk: a retrospective cohort study
title_short Herpes zoster and long-term vascular risk: a retrospective cohort study
title_sort herpes zoster and long-term vascular risk: a retrospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911591/
https://www.ncbi.nlm.nih.gov/pubmed/36759695
http://dx.doi.org/10.1038/s41598-023-29667-w
work_keys_str_mv AT horevamir herpeszosterandlongtermvascularriskaretrospectivecohortstudy
AT horevanat herpeszosterandlongtermvascularriskaretrospectivecohortstudy
AT gordonirshaiadi herpeszosterandlongtermvascularriskaretrospectivecohortstudy
AT gordonmichal herpeszosterandlongtermvascularriskaretrospectivecohortstudy
AT andrenicolas herpeszosterandlongtermvascularriskaretrospectivecohortstudy
AT iferganegal herpeszosterandlongtermvascularriskaretrospectivecohortstudy